DTSec Diabetes Technology Society Mobile Platform Controlling a Diabetes Device Security and Safety Standard

BackgroundPeopleDTMoSt GuidanceDTSec StandardProtection ProfileExtended Package: Enhanced BasicExtended Package: Moderate

 

Diabetes Technology Society (DTS) is developing its second cybersecurity standard, called the Diabetes Technology Society Mobile Platform Controlling a Diabetes Device Security and Safety Standard (DTMoSt). This document is a guidance that expands upon the principles of the DTS Cybersecurity Standard for Connected Diabetes Devices (DTSec), DTS’ first cybersecurity standard.  DTMoSt applies these principles to the use of mobile phones to control actions by wearable or implantable diabetes devices. DTMoSt aims to provide assurance that off-the-shelf consumer mobile phones can safely control diabetes devices. This guidance is for industry, clinicians, patients, payers, and regulators.

The standard was open to public comment for 45 days, from February 7, 2018 through March 24, 2018. We will answer all comments that were submitted.

DTSecCertified Devices

Device Certification
CONTOUR©NEXT ONE
(Manufacturer: Ascensia Diabetes Care)
CONTOUR©PLUS ONE
(Manufacturer: Ascensia Diabetes Care)

DTSecApproved Testing Labs

Booz Allen Hamilton
Cyber Assurance Testing Lab (CATL)
Primary Contact: Eric Winterton
Email: catl@bah.com
BrightSight
Primary Contact: Ernst Bovelander
Email: bovelander@brightsight.com
TUV Rheinland TÜV Rheinland — North America
Primary Contact: Uwe Meyer
Email: umeyer@us.tuv.com
Underwriters Laboratories Logo Underwriters Laboratories (UL)
Primary Contact Name: Anura S. Fernando
E-mail: Anura.S.Fernando@ul.com
For inquiries regarding how to become an approved DTSec lab, please contact info@diabetestechnology.org.

Public Comment about DTMoSt is solicited

Diabetes Technology Society (DTS) is developing its second cybersecurity standard, called the Diabetes Technology Society Mobile Platform Controlling a Diabetes Device Security and Safety Standard (DTMoSt). This document is a guidance that expands upon the principles of the DTS Cybersecurity Standard for Connected Diabetes Devices (DTSec), DTS’ first cybersecurity standard.  DTMoSt applies these principles to the use of mobile phones to control actions by wearable or implantable diabetes devices. DTMoSt aims to provide assurance that off-the-shelf consumer mobile phones can safely control diabetes devices. This guidance is for industry, clinicians, patients, payers, and regulators.

The DTMoSt Steering Committee includes representatives from: 1) the US government, including FDA, DHS, FBI, NIH, NASA, and DoD; 2) the Australian government; 3) professional organizations, including ADA, The Endocrine Society, and AADE; 4) Standards Development Organizations, including IEEE and UL; 5) industry, including mobile phone manufacturers, hardware and software manufacturers, medical device manufacturers, and medical device testing labs 6) academicians from medicine, diabetes education, information technology, engineering, mathematics, and law; and 7) patients.

We are soliciting public comment about the Guidance document (which relates to the DTSec Standard and DTSec Protection Profile) and the two new extended packages called Advanced Basic and Extended Moderate, which together replace what was preciously a single assurance package within DTSec.  The public comment period will be 45 days from February 7, 2018 through March 24, 2018.  We will answer all comments.  Please fill in the boxes on this DTMoSt website to submit comments.

Thank you,

David Klonoff, Chair, DTMoSt Steering Committee
David Kerr, Chair, DTMoSt Steering Committee
Dave Kleidermacher, Technical Chair, DTMoSt Steering Committee
Barry Ginsberg, Assistant Chair, DTMoSt Steering Committee